FY24 consensus $4.66. Abbott maintains its full-year 2024 organic sales growth guidance range of 9.5%-10.0%, excluding COVID-19 testing-related sales. FY24 revenue consensus $41.74B.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Options Volatility and Implied Earnings Moves Today, October 16, 2024
- Notable companies reporting before tomorrow’s open
- Johnson & Johnson reported strong earnings beat, says Barclays
- Abbott price target raised to $129 from $122 at Raymond James
- Options Volatility and Implied Earnings Moves This Week, October 15 – October 18, 2024